Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure

Recruiting N/A Interventional Study
Fetal Alcohol Spectrum Disorders Attention Deficit Hyperactivity Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
8 – 12
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
30 (estimated)
Sponsor
University of California, Los Angeles · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This is an open-label trial of trigeminal nerve stimulation (TNS) for children aged 8-12 years with attention deficit hyperactivity disorder (ADHD) putatively due to prenatal alcohol exposure (PAE). TNS has been successful in treating pediatric ADHD generally and it is US Food and Drug Administration (FDA)-cleared for this condition. But this will be the first time it is tried for ADHD specificall…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * \- Fetal alcohol syndrome, partial fetal alcohol syndrome, or alcohol-related neurodevelopmental disorder per modified Institute of Medicine criteria (thus positive maternal drinking in pregnancy required, facial stigmata not required) * Prenatal alcohol exposure (PAE) \>6 dri…
Contacts

Jennifer M Korthas, BS

(310) 267-2710

ChildBrainStudy@mednet.ucla.edu

CONTACT

Joseph O'Neill, PhD

(310) 825-5709

joneill@mednet.ucla.edu

CONTACT